This is an interviewee-led case that requires diagnostic thinking to identify that the client has inverted approval rates compared to industry peers. The root cause is lax early-stage approval standards leading to more expensive later-stage testing, increasing per-drug costs despite launching the same number of products. The candidate must synthesize this insight and generate creative solutions around operational improvements.